Searched for
PAEDIATRIC WELLNESS PRODUCTS
Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...- Cipla shares in focus after deal to acquire Inzpera Healthsciences for Rs 111 croreCipla shares: Cipla has agreed to acquire a 100% stake in Inzpera Healthsciences, making it a wholly owned subsidiary, as part of its strat...
- Cipla to fully acquire Inzpera HealthscienceDrug maker Cipla has acquired Inzpera Healthscience for approximately Rs 111 crore. This strategic move combines Inzpera's paediatric produ...
- This stock is benefiting from India's growing pediatric healthcare market. Why is this stock is the analyst pick of the week?India’s low spending on childcare products and services, high birth rate compared to China and the United States, increasing maternity age,...
- Dr Reddy's to promote, distribute Sanofi vaccine brands in IndiaThe announcement comes a day after Sanofi Healthcare India announced a separate partnership with Cipla to boost access to Sanofi's central ...
- Pandemic hasn't been good for cancer research: Harold E VarmusCovid-19 hasn't been good for cancer research as all the focus was on the pandemic. Despite important learnings from Covid-19 on immunother...
- Zydus' US subsidiary acquires speciality drug asset in USUnder the terms of the agreement, Sentynl will acquire global rights to Nulibry and will be responsible for the ongoing development and com...
- Healthtech platform Cloudphysician raises $4 million from Elevar EquityHealthtech platform Cloudphysician will use the funding to expand its global footprint and invest in strengthening its teams across vertica...
- Glenmark gets marketing approval for Ryaltris in 13 EU, UK countriesSales of the nasal spray continue to progress well in Australia, South Africa, Ukraine and Uzbekistan, it said adding the company has also ...
- Biocon Biologics, Serum Institute Life Sciences to expand tie-up for R&D, new vaccinesOn Thursday, Biocon had said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about Rs3...
- Paediatric task force, genome sequencing labs & buffer stock of medicines: Delhi CM lays out plan to counter 3rd Covid waveKejriwal announced the setting up of a paediatric task force and two genome sequencing labs as well as a plan to ramp up oxygen capacity to...
- View: Covid 3rd wave to attack kids, here's how India should prepare for itAccording to one of India’s best virologists, Dr Ravi from Nimhans Bengaluru, the third wave is likely to attack children, since most adult...
- Shantha Biotechnics aims for Rs 500-crore sales from paediatric drug relaunchSanofi, which acquired Shantha Bio in September 2009, said it spent over Rs 1,000 crore ($125 million) to expand production capacities, man...
- Dhathri Group targets Rs 200 crore turnoverDhathri Group aims to double its turnover to Rs 200 crore in the current fiscal.
- Innovation key to ride vaccine boom: Dr Rajesh Jain, Panacea BiotecIt is a capital-intensive business where companies require upfront payments to fund R&D activities, says Dr Rajesh Jain, joint managing dir...
- Pharma major, Sun, back on growth trackAfter facing a regulatory clampdown by the US FDA in 2009, Caraco has had its manufacturing suspended. It now sells distributed products.
- Indian school foundation laid in DubaiIn order to offer Indian curriculum as prescribed by the CBSE, the foundation stone for a International Indian High School (IIHS) has been ...
- Lupin close to speciality pharma buy in AmericaDrug maker Lupin plans to acquire a speciality pharmaceutical company in the United States to expand its portfolio of brands in the paediat...
- Sanofi arm may make India global output hub for vaccinesIndia may be a possible location as a global manufacturing base for vaccines business of Sanofi-Aventis Group.
- Max Health may be on ADAG radarThe buzz about Reliance Anil Dhirubhai Ambani group (ADAG)’s shopping spree is about Max Healthcare.
Load More
